<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2-ppt (info@mypapit.net)" -->
<?xml-stylesheet href="http://www.ctaf.org/feed.css" type="text/css"?>
<?xml-stylesheet href="http://www.ctaf.org/feed-rss.xsl" type="text/xsl"?>
<rss version="2.0">
    <channel>
        <title>California Technology Assessment Forum</title>
        <description>California Technology Assessment Forum</description>
        <link>http://www.ctaf.org/</link>
        <lastBuildDate>Sat, 13 Mar 2010 12:06:01 GMT</lastBuildDate>
        <generator>FeedCreator 1.7.2-ppt (info@mypapit.net)</generator>
        <item>
            <title>Transurethral Microwave Thermotherapy for the Treatment of Benign Prostatic Hyperplasia</title>
            <link>http://www.ctaf.org/content/assessment/detail/1075/</link>
            <description><![CDATA[It is recommended that transurethral microwave thermotherapy meets CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes for the treatment of benign prostatic hyperplasia in men with moderately severe obstructive symptoms and prostate volume of 30-100mL, with no history of prostate procedures, and without prostate cancer.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 29 Oct 2009 02:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1075/</guid>
        </item>
        <item>
            <title>Extracorporeal Shockwave Therapy (ESWT) for Plantar Fasciitis not Responding to Conservative Therapy</title>
            <link>http://www.ctaf.org/content/assessment/detail/1074/</link>
            <description><![CDATA[It is recommended that the use of ESWT for the treatment of plantar fasciitis does not meet technology assessment criteria 3, 4, or 5 for safety, effectiveness, and improvement in health outcomes.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 29 Oct 2009 02:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1074/</guid>
        </item>
        <item>
            <title>Artificial Disc Replacement for Degenerative Disc Disease of the Cervical Spine</title>
            <link>http://www.ctaf.org/content/assessment/detail/1073/</link>
            <description><![CDATA[It is recommended that cervical disc replacement as an alternative to spinal fusion does not meet CTAF criteria 3-5 for improvement in health outcomes.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 29 Oct 2009 02:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1073/</guid>
        </item>
        <item>
            <title>Laparoscopic Adjustable Silicone Gastric Banding for Obesity</title>
            <link>http://www.ctaf.org/content/assessment/detail/1072/</link>
            <description><![CDATA[It is recommended that the use of LAGB for the treatment of obesity meets CTAF technology assessment criteria 1 through 5 for safety, effectiveness and improvement in health outcomes.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 29 Oct 2009 02:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1072/</guid>
        </item>
        <item>
            <title>CTAF Meeting</title>
            <link>http://www.ctaf.org/content/calendar/detail/1049/</link>
            <description></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Tue, 13 Oct 2009 04:00:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/calendar/detail/1049/</guid>
        </item>
        <item>
            <title>CTAF Meeting</title>
            <link>http://www.ctaf.org/content/calendar/detail/1048/</link>
            <description></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Tue, 13 Oct 2009 04:00:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/calendar/detail/1048/</guid>
        </item>
        <item>
            <title>CTAF Meeting</title>
            <link>http://www.ctaf.org/content/calendar/detail/1047/</link>
            <description></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Mon, 12 Oct 2009 03:45:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/calendar/detail/1047/</guid>
        </item>
        <item>
            <title>Andrew Robertson, MD, MMM</title>
            <link>http://www.ctaf.org/content/member/detail/1041/</link>
            <description></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Fri, 02 Oct 2009 23:00:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/member/detail/1041/</guid>
        </item>
        <item>
            <title>Hypofractionated Whole Breast Radiation Therapy Following Breast- conserving Surgery</title>
            <link>http://www.ctaf.org/content/assessment/detail/1039/</link>
            <description><![CDATA[It is recommended that the use of hypofractionation meets CTAF technology assessment criteria 1 through 5 for safety, effectiveness and improvement in health outcomes when used as adjuvant radiation therapy following breast surgery for localized breast cancer in the fully informed patient.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Wed, 11 Mar 2009 22:30:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1039/</guid>
        </item>
        <item>
            <title>Portable Devices Used in Home Testing for Obstructive Sleep Apnea</title>
            <link>http://www.ctaf.org/content/assessment/detail/1038/</link>
            <description><![CDATA[It is recommended that the use of two portable home devices (Remmers Sleep Recorder, WatchPat) to diagnose OSA meets technology assessment criteria 1 through 5 for safety, effectiveness and improvement in health outcomes in patients at very high risk for OSA and unlikely to have another cause for their sleepiness.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Wed, 11 Mar 2009 22:30:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1038/</guid>
        </item>
        <item>
            <title>Repetitive Transcranial Magnetic Stimulation for Treatment Resistant Depression</title>
            <link>http://www.ctaf.org/content/assessment/detail/1028/</link>
            <description><![CDATA[It is recommended that repetitive transcranial magnetic stimulation does not meet CTAF TA criteria 3-5 for efficacy and improvement in health outcomes in patients with treatment resistant depression.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 18 Jun 2009 03:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1028/</guid>
        </item>
        <item>
            <title>Assessing Cardiovascular Disease Risk with hs C-reactive Protein</title>
            <link>http://www.ctaf.org/content/assessment/detail/1027/</link>
            <description><![CDATA[It is recommended that measurement of hs-CRP does not meet CTAF criteria 3--5 for effectiveness and improvement in health outcomes compared with no testing.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 18 Jun 2009 03:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1027/</guid>
        </item>
        <item>
            <title>Carotid Artery Stenting</title>
            <link>http://www.ctaf.org/content/assessment/detail/1026/</link>
            <description><![CDATA[It is recommended that carotid artery angioplasty with stenting does not meet CTAF TA criteria 3 through 5 for improvement in health outcomes.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 18 Jun 2009 03:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1026/</guid>
        </item>
        <item>
            <title>Balloon Kyphoplasty as a Treatment for Vertebral Compression Fractures</title>
            <link>http://www.ctaf.org/content/assessment/detail/1025/</link>
            <description><![CDATA[It is recommended that balloon kyphoplasty with PMMA meets CTAF criteria 1-5 for safety, effectiveness and improvement in health outcomes for the treatment of recent (< 3mo. old) osteoporotic vertebral compression fractures confirmed by MRI.

It is further recommended that balloon kyphoplasty does not meet CTAF criteria 3-5 for effectiveness and improvement in health outcomes for the treatment of chronic (>3mo.old) osteoporotic, traumatic or pathologic vertebral compression fractures.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Thu, 18 Jun 2009 03:15:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/1025/</guid>
        </item>
        <item>
            <title>Computed Tomography Colonography (Virtual Colonoscopy) for Colorectal Cancer Screening in ...</title>
            <link>http://www.ctaf.org/content/assessment/detail/989/</link>
            <description><![CDATA[It is recommended that CTC does not meet CTAF TA criteria 3, 4 or 5 as a screening test for CRC in average risk individuals.]]></description>
            <author>California Technology Assessment Forum</author>
            <pubDate>Wed, 11 Mar 2009 04:00:00 GMT</pubDate>
            <guid>http://www.ctaf.org/content/assessment/detail/989/</guid>
        </item>
    </channel>
</rss>
